Seven Eight Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Seven Eight Capital’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,141	Closed	-$1.6M	–	806
2019 Q4	$1.6M	Buy	+67,141	New	+$1.85M	0.09%	354
2017 Q2	–	Sell	-10,200	Closed	-$400K	–	719
2017 Q1	$400K	Buy	+10,200	New	+$325K	0.08%	295
2016 Q1	–	Sell	-1,000	Closed	-$51K	–	725
2015 Q4	$51K	Buy	+1,000	New	+$48.5K	0.03%	434

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Seven Eight Capital's PTLA Position: Q1 2020 in Review

Seven Eight Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 67,141 shares — an estimated $1.6M sold.

Seven Eight Capital first reported a position in PTLA in Q4 2015 and held it in 3 quarters. The position peaked at $1.6M in Q4 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Seven Eight Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Seven Eight Capital sold 67,141 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.6M.
Seven Eight Capital first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
Seven Eight Capital's Portola Pharmaceuticals, Inc. position peaked at $1.6M in Q4 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Seven Eight Capital's 13F filing for Q1 2020, filed 14 May 2020.